Pharmaceutical companies clawed back losses suffered yesterday, but the FTSE 100 index is little cha...
Pharmaceutical companies clawed back losses suffered yesterday, but the FTSE 100 index is little changed, up 4 points to 3,933.
The latest house price survey from Nationwide indicates house price inflation is coming down, which could translate into lower future consumer spending, but this is countered by yesterday's figures showing consumers spending in April rebounded strongly from falls in February and March.
But medicine still looked like a safe-haven this morning.
Amersham leads the gainers with a 24p rise to 445.5p.
AstraZenica, one of yesterday's losers, is up 56p to £24.32, and GlaxoSmithKline is up 12p to £12.41.
Alliance Unichem is up 9p to 458p and Boots is up 8p to 565p.
Legal & General is up 1.75p to 78.5p and Prudential is up 1.25p to 375.5p.
Xstrata continued the recent poor run for the mining sector by dropping 12p to 541p.
However, the momentum is clearly in favour of the index moving up as gainers outweigh losers by 60:40 on the last day of a month in which the index has gained nearly 10% in value, its best performance since 1992.
The FTSE 250 index is down 5 points to 4,350.
Kidde is down 3.75p to 70p, giving up the gains made yesterday when it reported positive first quarter results.
Brambles, the pallet supplier, is up 8.75p to 183.25p to lead the gainers.
ISIS Asset Management is up 5.5p to 171p.
Shares close up slightly in New York overnight.
The Dow Jones Industrial Average index gained 31.38 points to 8,502.99, the S&P 500 was up 3 points to 917.84, and Nasdaq's Composite is up 9.06 points to 1,471.30.
A question of selectivity
Watchdog interviewed 13,000 people
Debate over loyalty bonuses